• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床护理地点对 Medicare 受益人的外周血管介入治疗后临床结果的影响。

The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries.

机构信息

Department of Surgery, Duke University School of Medicine, Durham, North Carolina.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

出版信息

JACC Cardiovasc Interv. 2017 Jun 12;10(11):1161-1171. doi: 10.1016/j.jcin.2017.03.033.

DOI:10.1016/j.jcin.2017.03.033
PMID:28595885
Abstract

OBJECTIVES

Modifications in reimbursement rates by Medicare in 2008 have led to peripheral vascular interventions (PVI) being performed more commonly in outpatient and office-based clinics. The objective of this study was to determine the effects of this shift in clinical care setting on clinical outcomes after PVI.

BACKGROUND

Modifications in reimbursement have led to peripheral vascular intervention (PVI) being more commonly performed in outpatient hospital settings and office-based clinics.

METHODS

Using a 100% national sample of Medicare beneficiaries from 2010 to 2012, we examined 30-day and 1-year rates of all-cause mortality, major lower extremity amputation, repeat revascularization, and all-cause hospitalization by clinical care location of index PVI.

RESULTS

A total of 218,858 Medicare beneficiaries underwent an index PVI between 2010 and 2012. Index PVIs performed in inpatient settings were associated with higher 1-year rates of all-cause mortality (23.6% vs. 10.4% and 11.7%; p < 0.001), major lower extremity amputation (10.1% vs. 3.7% and 3.5%; p < 0.001), and all-cause repeat hospitalization (63.3% vs. 48.5% and 48.0%; p < 0.001), but lower rates of repeat revascularization (25.1% vs. 26.9% vs. 38.6%; p < 0.001) when compared with outpatient hospital settings and office-based clinics, respectively. After adjustment for potential confounders, patients treated in office-based clinics remained more likely than patients in inpatient hospital settings to require repeat revascularization within 1 year across all specialties. There was also a statistically significant interaction effect between location of index revascularization and geographic region on the occurrence of all-cause hospitalization, repeat revascularization, and lower extremity amputation.

CONCLUSIONS

Index PVI performed in office-based settings was associated with a higher hazard of repeat revascularization when compared with other settings. Differences in clinical outcomes across treatment settings and geographic regions suggest that inconsistent application of PVI may exist and highlights the need for studies to determine optimal delivery of PVI in clinical practice.

摘要

目的

2008 年医疗保险报销费率的调整使得外周血管介入(PVI)更多地在门诊和诊所进行。本研究的目的是确定临床治疗环境的这种转变对外周血管介入后临床结果的影响。

背景

报销费率的调整使得外周血管介入(PVI)更多地在门诊医院环境和诊所进行。

方法

使用 2010 年至 2012 年 Medicare 受益人的全国 100%样本,我们根据 PVI 索引的临床治疗地点,检查了 30 天和 1 年的全因死亡率、主要下肢截肢、重复血运重建和全因住院率。

结果

共有 218858 名 Medicare 受益人的 PVI 索引在 2010 年至 2012 年之间进行。在住院环境中进行的 PVI 索引与更高的 1 年全因死亡率(23.6%比 10.4%和 11.7%;p<0.001)、主要下肢截肢(10.1%比 3.7%和 3.5%;p<0.001)和全因再次住院(63.3%比 48.5%和 48.0%;p<0.001)相关,但与门诊医院环境和诊所相比,重复血运重建的比率较低(25.1%比 26.9%和 38.6%;p<0.001)。在调整了潜在的混杂因素后,与住院医院环境相比,在所有专科中,在诊所接受治疗的患者在 1 年内再次血运重建的可能性仍然更高。索引血运重建的位置和地理区域之间也存在显著的交互作用,影响全因住院、重复血运重建和下肢截肢的发生。

结论

与其他环境相比,在诊所进行的 PVI 索引与更高的重复血运重建风险相关。治疗环境和地理区域之间的临床结果差异表明,可能存在 PVI 的不一致应用,并强调需要研究确定 PVI 在临床实践中的最佳应用。

相似文献

1
The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries.临床护理地点对 Medicare 受益人的外周血管介入治疗后临床结果的影响。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1161-1171. doi: 10.1016/j.jcin.2017.03.033.
2
Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease.比较慢性肢体威胁性缺血合并伴发慢性肾脏病患者下肢旁路与外周血管介入治疗后的死亡率和截肢率。
J Vasc Surg. 2024 Aug;80(2):480-489.e5. doi: 10.1016/j.jvs.2024.04.016. Epub 2024 Apr 10.
3
Practice patterns of peripheral vascular interventions for peripheral artery disease in the office-based laboratory setting versus outpatient hospital.在诊室内的基础实验室环境与门诊医院中,外周血管疾病的外周血管介入治疗的实践模式。
J Vasc Surg. 2024 Nov;80(5):1525-1536.e7. doi: 10.1016/j.jvs.2024.06.006. Epub 2024 Jun 20.
4
Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention.合并症的差异解释了股浅动脉血管内介入治疗后黑种人和白人结局的差异。
Circulation. 2022 Jul 19;146(3):191-200. doi: 10.1161/CIRCULATIONAHA.122.058998. Epub 2022 Jun 13.
5
Association of Clinical Setting With Sociodemographics and Outcomes Following Endovascular Femoropopliteal Artery Revascularization in the United States.美国血管腔内股浅动脉血运重建术后临床环境与社会人口统计学及结局的关联。
Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009199. doi: 10.1161/CIRCOUTCOMES.122.009199. Epub 2022 Dec 6.
6
Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative.血管质量倡议中严重肢体缺血患者开放手术与血管内治疗的比较
J Vasc Surg. 2016 Apr;63(4):958-65.e1. doi: 10.1016/j.jvs.2015.09.063. Epub 2016 Jan 28.
7
Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system.外周血管介入治疗环境的变化趋势及门诊预期支付制度变化的影响。
J Am Coll Cardiol. 2015 Mar 10;65(9):920-7. doi: 10.1016/j.jacc.2014.12.048.
8
The disproportionate growth of office-based atherectomy.基于办公室的斑块旋切术的不成比例增长。
J Vasc Surg. 2017 Feb;65(2):495-500. doi: 10.1016/j.jvs.2016.08.112. Epub 2016 Dec 13.
9
Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative.医疗保险相关血管质量倡议中,慢性肢体威胁性缺血的下肢旁路与外周血管介入治疗比较。
J Vasc Surg. 2023 Sep;78(3):745-753.e6. doi: 10.1016/j.jvs.2023.05.015. Epub 2023 May 18.
10
Long-term outcomes in the smoking claudicant after peripheral vascular interventions.吸烟性跛行患者外周血管介入治疗后的长期结局。
J Vasc Surg. 2024 Jul;80(1):165-174. doi: 10.1016/j.jvs.2024.02.033. Epub 2024 Mar 2.

引用本文的文献

1
Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血患者全国队列的建立与描述
J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100982. doi: 10.1016/j.jscai.2023.100982. eCollection 2023 Jul-Aug.
2
Trends and Factors Associated With Peripheral Vascular Interventions for the Treatment of Claudication From 2011 to 2022: A National Medicare Cohort Study.2011 年至 2022 年治疗间歇性跛行的外周血管介入治疗的趋势和相关因素:一项全国性医疗保险队列研究。
J Am Heart Assoc. 2024 Jul 16;13(14):e033463. doi: 10.1161/JAHA.123.033463. Epub 2024 Jul 3.
3
Outcomes of atherectomy in patients undergoing lower extremity revascularisation.
下肢血运重建患者经腔内斑块旋切术的治疗结果。
EuroIntervention. 2023 Dec 18;19(11):e955-e963. doi: 10.4244/EIJ-D-23-00432.
4
Peripheral Arterial Disease Treatment in the Non-Hospital Setting.非医院环境下的外周动脉疾病治疗
Semin Intervent Radiol. 2023 Jun 16;40(2):193-196. doi: 10.1055/s-0043-57265. eCollection 2023 Apr.
5
Association of Clinical Setting With Sociodemographics and Outcomes Following Endovascular Femoropopliteal Artery Revascularization in the United States.美国血管腔内股浅动脉血运重建术后临床环境与社会人口统计学及结局的关联。
Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009199. doi: 10.1161/CIRCOUTCOMES.122.009199. Epub 2022 Dec 6.
6
Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population.在 Medicare 人群中,使用胫骨介入治疗跛行的实践模式。
J Vasc Surg. 2023 Feb;77(2):454-462.e1. doi: 10.1016/j.jvs.2022.08.033. Epub 2022 Sep 1.
7
Use of Atherectomy During Index Peripheral Vascular Interventions.在指数外周血管介入治疗中使用旋切术。
JACC Cardiovasc Interv. 2021 Mar 22;14(6):678-688. doi: 10.1016/j.jcin.2021.01.004.
8
Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene.真实世界证据:钠-葡萄糖共转运蛋白 2 抑制剂的使用与 Fournier 坏疽风险的关系
BMJ Open Diabetes Res Care. 2020 Jan;8(1). doi: 10.1136/bmjdrc-2019-000985.
9
Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.钠-葡萄糖协同转运蛋白 2 抑制剂的使用与下肢截肢风险:不断变化的问题,不断变化的答案。
Diabetes Obes Metab. 2019 May;21(5):1223-1236. doi: 10.1111/dom.13647. Epub 2019 Mar 4.
10
ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.美国心脏病学会适当使用标准工作组、美国心脏协会、心血管血管造影和介入学会、介入放射学会和血管医学学会 2018 年外周动脉介入适当使用标准:一份报告
J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. doi: 10.1016/j.jacc.2018.10.002. Epub 2018 Dec 17.